Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results
May 10
U.K. (FTSE) Healthcare Sector Analysis
UpdatedMay 10, 2024
DataAggregated Company Financials
Companies98
- 7D2.1%
- 3M17.8%
- 1Y5.9%
- YTD13.7%
In the last week, the Healthcare industry is up 2.1%, with AstraZeneca up 1.4%. This takes the industry's 12 month performance to a gain of 5.9%. Looking forward, earnings are forecast to grow by 15% annually.
Sector Valuation and Performance
Has the U.K. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | UK£295.2b | UK£82.4b | UK£9.4b | 33.7x | 31.3x | 3.6x |
| Sun, 07 Apr 2024 | UK£263.8b | UK£81.1b | UK£9.6b | 32.9x | 27.5x | 3.3x |
| Tue, 05 Mar 2024 | UK£256.3b | UK£80.8b | UK£9.6b | 33.3x | 26.8x | 3.2x |
| Thu, 01 Feb 2024 | UK£272.7b | UK£84.1b | UK£10.7b | 38.7x | 25.6x | 3.2x |
| Sat, 30 Dec 2023 | UK£270.1b | UK£83.9b | UK£10.6b | 40.4x | 25.4x | 3.2x |
| Mon, 27 Nov 2023 | UK£260.9b | UK£84.4b | UK£10.7b | 40.8x | 24.4x | 3.1x |
| Wed, 25 Oct 2023 | UK£262.3b | UK£86.1b | UK£10.3b | 39.9x | 25.5x | 3x |
| Fri, 22 Sep 2023 | UK£279.7b | UK£85.6b | UK£10.3b | 40.4x | 27.2x | 3.3x |
| Sun, 20 Aug 2023 | UK£268.9b | UK£83.9b | UK£10.1b | 40.3x | 26.5x | 3.2x |
| Tue, 18 Jul 2023 | UK£260.5b | UK£81.4b | UK£7.8b | 44.2x | 33.5x | 3.2x |
| Thu, 15 Jun 2023 | UK£283.6b | UK£82.7b | UK£7.9b | 47.4x | 35.9x | 3.4x |
| Sat, 13 May 2023 | UK£296.4b | UK£83.5b | UK£8.0b | 49.3x | 37.2x | 3.5x |
| Mon, 10 Apr 2023 | UK£290.0b | UK£84.2b | UK£6.9b | 45x | 41.9x | 3.4x |
| Wed, 08 Mar 2023 | UK£276.2b | UK£86.4b | UK£7.0b | 43x | 39.4x | 3.2x |
| Fri, 03 Feb 2023 | UK£267.7b | UK£85.3b | UK£6.6b | 37.3x | 40.8x | 3.1x |
| Sun, 01 Jan 2023 | UK£281.6b | UK£95.2b | UK£6.6b | 36.4x | 42.6x | 3x |
| Tue, 29 Nov 2022 | UK£277.2b | UK£95.4b | UK£6.6b | 37.9x | 41.8x | 2.9x |
| Thu, 27 Oct 2022 | UK£258.6b | UK£94.9b | UK£4.0b | 29.9x | 64.5x | 2.7x |
| Sat, 24 Sep 2022 | UK£254.3b | UK£97.8b | UK£4.0b | 31.9x | 63.7x | 2.6x |
| Mon, 22 Aug 2022 | UK£282.8b | UK£93.8b | UK£4.0b | 35.7x | 70x | 3x |
| Wed, 20 Jul 2022 | UK£308.9b | UK£90.6b | UK£4.9b | 34.1x | 62.8x | 3.4x |
| Fri, 17 Jun 2022 | UK£283.1b | UK£88.8b | UK£5.0b | 27.9x | 56.9x | 3.2x |
| Sun, 15 May 2022 | UK£298.1b | UK£89.0b | UK£5.0b | 28.3x | 59.7x | 3.3x |
| Tue, 12 Apr 2022 | UK£315.2b | UK£81.2b | UK£5.1b | 35.8x | 61.6x | 3.9x |
| Thu, 10 Mar 2022 | UK£274.6b | UK£80.8b | UK£5.1b | 31.5x | 54.3x | 3.4x |
| Sat, 05 Feb 2022 | UK£270.1b | UK£75.3b | UK£6.0b | 32.3x | 44.9x | 3.6x |
| Mon, 03 Jan 2022 | UK£285.0b | UK£75.3b | UK£6.0b | 32.4x | 47.2x | 3.8x |
| Wed, 01 Dec 2021 | UK£272.1b | UK£76.0b | UK£6.1b | 30.3x | 44.7x | 3.6x |
| Fri, 29 Oct 2021 | UK£285.5b | UK£72.2b | UK£7.7b | 30.2x | 37x | 4x |
| Sun, 26 Sep 2021 | UK£273.6b | UK£71.9b | UK£8.0b | 33.9x | 34.3x | 3.8x |
| Tue, 24 Aug 2021 | UK£274.2b | UK£71.4b | UK£7.9b | 32.8x | 34.9x | 3.8x |
| Wed, 30 Jun 2021 | UK£251.2b | UK£71.2b | UK£7.8b | 37.9x | 32.2x | 3.5x |
Price to Earnings Ratio
27.2x
Current Industry PE
- Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 31.3x which is lower than its 3-year average PE of 43.4x.
- The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 2.6% per year over the last three years.
- Revenues for these companies have grown 6.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare sector?
| GB Market | 2.26% | |
| Healthcare | 2.07% | |
| Life Sciences | 8.28% | |
| Biotech | 3.67% | |
| Medical Equipment | 3.07% | |
| Healthcare Services | 2.74% | |
| Pharma | 1.96% | |
| Healthtech | 0.77% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 90.5x.
- Analysts are expecting annual earnings growth of 22.1%, which is higher than its past year's earnings decline of 2.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 30% over the next 5 years.
- This is better than its past earnings decline of 12% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AZN AstraZeneca | UK£123.32 | 1.4% +UK£2.7b | 3.4% | PE37.8x | |
| GSK GSK | UK£17.81 | 3.0% +UK£2.1b | 23.2% | PE16.2x | |
| CTEC ConvaTec Group | UK£2.62 | 5.0% +UK£253.8m | 19.9% | PE51.5x | |
| HCM HUTCHMED (China) | UK£3.38 | 9.0% +UK£239.0m | 44.4% | PE35.9x | |
| SN. Smith & Nephew | UK£10.02 | 1.6% +UK£138.6m | -21.5% | PE41.6x |
